Communiqués Willow Biosciences Inc.

Actions

WLLW

CA97111B4047

Cours en clôture Toronto S.E. Autres places de cotation 00:00:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
0,11 ^CAD	+10,00%		+4,76%	+10,00%

26/06	Willow Biosciences fait le point sur ses activités et signe un nouveau programme en partenariat	MT
30/05	Willow Biosciences Inc. annonce un partenariat de développement et de licence multiproduits avec Laurus Labs	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM	26/06	AQ
Willow Bioscience Announces 3 Million dollar Fundraising to Support Partnership with Laurus Labs	07/06	AQ
WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION	03/06	AQ
WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS	30/05	AQ
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	29/03	AQ
WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	31/01	AQ
WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	16/01	AQ
Willow Bioscience plans to advance development program with Nasdaq-listed company	11/12	AQ
WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	15/11	AQ
WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING	11/10/23	AQ
Willow Bioscience teams again with Suanfarma on large volume anti-infective API	05/10/23	AQ
WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION	03/10/23	AQ
Willow Bioscience eyes another use for BioOxi platform with R&D of ursodeoxycholic acid	12/09/23	AQ
WILLOW BIOSCIENCES ANNOUNCES COMPANY INSIDER LED CONVERTIBLE DEBENTURE FINANCING	12/09/23	AQ
WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCA	06/09/23	AQ
Willow Bioscience files patent to help reduce costs of corticosteroids	04/09/23	AQ
WILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COST	31/08/23	AQ
Willow Bioscience shifts focus to opportunity with BioOxi bio-oxidation platform	29/08/23	AQ
WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS	08/08/23	AQ
WILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON AUGUST 9	02/08/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Willow Biosciences Inc.

Actions

WLLW

CA97111B4047

Communiqués

Filtres